Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.41Last Year’s EPS
-0.4Same Quarter Last Year
Strong Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call showcased strong revenue growth, increased handpiece sales, improved gross margins, and favorable Medicare updates, indicating positive operational momentum. However, challenges such as the timing of system sales, increased operating expenses, continued net loss, and leadership transitions were highlighted as potential concerns. Despite these challenges, the overall sentiment is positive due to the significant achievements and potential for future growth.Company Guidance -
Q3 2025
Strong Quarterly Revenue Growth
Total revenue for the second quarter of 2025 was $79.2 million, representing growth of 48% compared to the second quarter of 2024. U.S. revenue grew by 46%, and international revenue grew by 69% compared to the prior year period.
Increased Handpiece Sales
Handpiece and other consumable revenue for the second quarter of 2025 was $43.1 million, representing growth of 58% compared to the second quarter of 2024, with 12,750 handpieces sold, marking a 59% year-over-year unit growth.
Improved Gross Margins
Gross margin for the second quarter of 2025 was 65.4%, an increase of 640 basis points year-over-year, driven by improved operational efficiencies and higher average selling prices.
Favorable Tariff Developments
Chinese tariff rates have declined to approximately 55%, reducing the estimated cost of goods sold headwinds in the second half of 2025 to approximately $1 million to $2 million from the previously estimated $5 million.
Positive Medicare Updates
Aquablation therapy was assigned a Category I CPT code effective January 1, 2026, with a proposed payment of 16.14 total RVUs, marking a significant milestone for PROCEPT and reinforcing the clinical value and growing adoption of Aquablation therapy.
PRCT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRCT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $45.69 | $39.59 | -13.35% |
Apr 24, 2025 | $55.70 | $52.56 | -5.64% |
Feb 25, 2025 | $62.71 | $68.11 | +8.61% |
Oct 28, 2024 | $68.77 | $91.00 | +32.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does PROCEPT BioRobotics (PRCT) report earnings?
PROCEPT BioRobotics (PRCT) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is PROCEPT BioRobotics (PRCT) earnings time?
PROCEPT BioRobotics (PRCT) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRCT EPS forecast?
PRCT EPS forecast for the fiscal quarter 2025 (Q3) is -0.41.